News

Home / News

Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO.,LTD.,regarding acquisition of right-of-use asset from related

2024.12.27

1.Date of occurrence of the event:2024/12/27

2.Date of the original announcement and reporting:2024/04/01

3.Summary of the content originally announced and reported:
Leased the Taichung office, 4F.-1, No. 424, Zhongming Rd., Taichung City, Taiwan (R.O.C.),from the Parent Company of the Company, TSH Biopharm Corporation Limited. The contents of the original lease information are as follows:
Taichung office︰
Transaction unit amount:11 pings
Unit price:NT$450 per ping per month
Total monthly cost: NT$8,300 per month (including water, electricity, and management fees)
The lease period is from 2024/04/01-2025/12/31
Total right-of-use asset value: NT$171,076

4.Reason for change and its main content: On 2024/12/27the board of directors approved the renewal of the original lease contract period,and the updated information is as follows:
Taichung office︰
Transaction unit amount:11 pings
Unit price:NT$450 per ping per month
Total monthly cost: NT$8,300 per month(including water, electricity, cleaning and management fees)
The lease period is from 2025/01/01-2026/12/31
Total right-of-use asset value: NT$195,853

5.Effect on the Company’s finance and business after the change:NA

6.Any other matters that need to be specified:NA